Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-12-27

FDA Approved: AZELASTINE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

The FDA approved a supplemental application for Apotex Corp.'s azelastine hydrochloride product, confirming regulatory approval for this generic formulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZELASTINE HYDROCHLORIDE (azelastine hydrochloride)

Snippet

SUPPL AP for AZELASTINE HYDROCHLORIDE (AZELASTINE HYDROCHLORIDE)